the outcomes of patients with primary refractory and relapsed acute leukemia
Published 2 years ago • 48 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:34
single-center study evaluating the outcomes of patients with aml who relapsed after allosct
-
2:12
using a novel machine learning model to analyze and predict the outcomes of patients with ndmm
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
8:57
outcomes of sct in t-all and t-lbl
-
1:15
phase i trial of ina03 in patients with r/r acute leukemia: preliminary results
-
4:06
what is leukapheresis?
-
25:59
raven leukapheresis processing training video
-
9:44
what to expect during your inpatient allogeneic stem cell transplant
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:35
outcomes of allosct following blinatumomab in children and young adults with r/r b-all
-
6:50
improving the management of patients with newly diagnosed aml presenting with hyperleukocytosis
-
2:45
continuity of care for patients with hematological predispositions to aml
-
3:52
maintenance therapy with revumenib following allosct in kmt2ar and npm1-mutated acute leukemias
-
1:13
outcomes following fd & nfd related donor haplo transplantation for patients with acute leukemias
-
1:56
treatment selection & sequencing in patients with relapsed, intolerant, or refractory myeloma
-
3:40
outcomes of all stratified by socioeconomic factors
-
1:48
do all patients require maintenance therapy following allosct?
-
2:14
addressing the high rate of disease relapse following allosct in patients with aml
-
3:23
patient characteristics and outcomes of allosct for bpdcn
-
1:28
use of machine learning to predict outcomes for patients with scd
-
6:35
post-transplant bendamustine for gvhd prophylaxis in refractory acute leukemia